Publications by authors named "Genevieve Demeer"
High prevalence of behavioral and psychiatric disorders in adults with Prader-Willi Syndrome (PWS) has been reported in last few years. However, data are confusing and often contradictory. In this article, we propose a model to achieve a better understanding of the psychopathological features in adults with PWS.
View Article and Find Full Text PDFGrowth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood.
Muriel Coupaye Françoise Lorenzini Célia Lloret-Linares Catherine Molinas Graziella Pinto Geneviève Demeer
J Clin Endocrinol Metab
February 2013
Context: Children with Prader-Willi syndrome (PWS) who receive GH treatment have improved growth and body composition; however, data are lacking for adults when treatment is discontinued after completion of growth.
Objectives: Our aim was to compare body composition and metabolic status in adults with PWS according to GH treatment in childhood and adolescence.
Design: 64 adults (mean age: 25.
Article Synopsis
- Prader-Willi syndrome (PWS) is a genetic disorder marked by issues like hypothalamic dysfunction, obesity, and behavioral problems, linked to a reduction in oxytocin-producing neurons.
- In a controlled study, 24 adults with PWS were given either oxytocin or a placebo to evaluate its effects on social skills and behavior.
- Results showed that oxytocin administration improved trust, reduced sadness, and decreased disruptive behaviors two days post-treatment, suggesting a potential therapeutic avenue for managing behavioral issues in PWS.